Midline shift determined on magnetic resonance imaging (MRI) or computed tomography (CT) images is a well-validated marker of mass effect after large hemispheric infarction and associated with mortality. In this study, we targeted a population with moderately sized strokes. We compared midline shift to other imaging markers and determined their ability to predict long-term outcome.
Introduction
After acute ischemic stroke, development of edema 2-5 days after onset is a feared complication and often leads to secondary neurological injury. [1] [2] [3] Several measures of mass effect have been evaluated in malignant edema, including change in hemisphere volume, 4 cerebral spinal fluid (CSF) volumetric analysis, 5 and midline shift. 6 Midline shift is considered the gold standard, 7 and is measured as horizontal septum pellucidum displacement on computed tomography (CT) or magnetic resonance imaging (MRI). Midline shift is closely correlated with poor outcome 6 and also predicts early mortality. 8 However, midline shift may be visible only if the stroke lesion volume is large with substantial edema formation. Alternative markers such as change in lateral ventricle volume or hemisphere volume may be more sensitive to smaller changes in swelling, but have only been evaluated in large hemispheric stroke patients. 4 Alternatively, a region-of-interest-based analysis that compares baseline and follow-up MRI images from day 3 to 5 is able to distinguish infarct growth from lesional swelling volume. 9, 10 The presence of lesional swelling as determined with this method independently predicted poor outcome and mortality. 9 Lesional swelling is also associated with early neurological deterioration after stroke. 11 It has also been shown that lower lesional swelling volume was associated with early reperfusion. 10 To determine which imaging measures of mass effect are most suitable to predict outcome across a range of stroke volumes, we evaluated the relative performance of each marker in the Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET) cohort. We compared lesional swelling volumes, hemispheric swelling, and hemisphere ratio as well as change in lateral ventricle volume and midline shift, and compared their ability to predict long-term outcome. The coregistered follow-up (FU) DWI with the baseline lesion superimposed in blue. Newly infarcted tissue is outlined in red, and is excluded from the swelling volume measurement. The swelling volume corresponds to the region surrounding the blue baseline stroke lesion outline. (C) Outline of the ipsilateral (green) and contralateral (yellow) hemisphere. The relative change in hemisphere volume is the FU hemisphere volume minus the BL hemisphere volume divided by the BL hemisphere volume. The hemisphere ratio is calculated as the FU ipsilateral hemisphere volume divided by the FU contralateral hemisphere volume. (D) Outline of the ipsilateral (green) and contralateral (yellow) lateral ventricle volume. An analogous approach as in (C) was used to calculate CSF displacement measurements, except that the lateral ventricle volumes were used.
Methods Patients
Patients enrolled in the EPITHET (NCT00238537) were retrospectively analyzed. The EPITHET study was a randomized double-blind controlled phase 2 trial of alteplase t-PA in acute stroke performed in 15 centers in Australia, New Zealand, Belgium, and the UK. Details of the study cohort have been described. 12 In brief, acute hemispheric ischemic stroke patients with a National Institutes of Health stroke scale (NIHSS) score of more than 4 were included, received MRI imaging, and were treated with intravenous alteplase or placebo 3-6 hours after stroke onset. Global functional outcome was assessed at 90 days using the modified Rankin scale (mRS) score, and outcome was dichotomized into good (mRS 0-3) versus poor (mRS 4-6) outcome. Imaging was performed on 1.5 Tesla MRI scanners. Standardized diffusion-weighted imaging (DWI), perfusion imaging, and magnetic resonance angiography sequences were obtained before treatment, at days 3-5 as well as on day 90 to assess final infarct size when available. DWI consisted of 13-27 axial slices with a thickness of 5-7 mm. For the present analysis we included only patients who received baseline and follow-up MRI examination 3-5 days after onset with DWI.
Imaging Analysis Midline Shift
Using a DICOM viewer (RadiAnt, Version 2.2, Medixant), midline shift was measured at the point of maximal deviation from the line drawn between the anterior and posterior attachment of the falx cerebri on follow-up DWI only.
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Lesional Swelling Volume
The rest of the imaging analysis was performed with Analyze 11.0 (Biomedical Imaging Resource, Mayo Clinic, Rochester, MN). Analyze is an established image processing tool that has been used for the manual or semiautomated segmentation of biomedical images in numerous studies concerning varying neurological issues. 9, [15] [16] [17] [18] [19] The option to use the semiautomatic edge-finding tool makes it easier to segment regions of interest, like acute stroke lesions and hemisphere volumes. For determination of lesional swelling volumes, we used a method described in detail previously. [9] [10] [11] Briefly, DWI lesion volumes were determined on the baseline (BL) and the follow-up (FU) images independently, and stroke lesion expansion (DWI) was calculated. Subsequently, the FU image was coregistered onto the BL DWI and the mask for the BL lesion was superimposed onto the FU image ( Fig 1B) . Changes in stroke regions between BL and FU were designated infarct growth, swelling, or hemorrhagic transformation by comparing BL and FU MRI scans side-by-side in axial, sagittal, and transverse planes in the following way: Infarct growth was defined as involvement of new anatomic territory either adjacent to or distinct from the baseline lesion and delineated accordingly ( Figs 1A and B) . Hemorrhagic tissue was outlined as well. The final volumes were determined based on the relationship: Swelling volume = DWI − infarct growth − hemorrhage volume.
Hemisphere Volumes
Using Analyze 11.0, the cerebral hemisphere ipsi-and contralateral to the acute stroke on all relevant slices, but excluding cerebellum and brain stem, were delineated on BL and FU DWI (Fig 1C) . Major sulci, cisterns, and ventricles were excluded. From these measurements, the following metrics were derived: 
Lateral Ventricle Volumes
In the same way, the volume of the ipsi-and contralateral lateral ventricle was measured on all relevant slices for BL and FU (Fig 1D) . The following metrics were derived from these measurements: 
Statistics
Baseline characteristics were presented as median and interquartile range or frequency and percentage. Patients were split into subgroups with good (mRS 0-2) and poor (mRS 3-6) outcome at day 90. The differences between the analyzed markers of mass effect between the two groups were tested with the Mann-Whitney U test. Correlation between different markers of mass effect was assessed using Spearman testing. Logistic regression models were constructed to evaluate the association between imaging measures, with poor outcome and mortality as the dependent variables. Performance of each model was assessed using receiver-operating characteristic (ROC) curves, and the optimal threshold was identified by maximizing the sensitivity and specificity. These statistical analyses were performed using JMP Pro 11.0 (SAS Institute, Cary, NC) or MATLAB R2014b. ROC curves for the different imaging measures were compared using the StAR (Statistical Comparison of ROC Curves) online tool. 20 This tool is based on a nonparametric approach for comparison of two or more paired ROC curves.
21 Table 1 Values are median (interquartile range) or frequency (percentage). n = sample size; NIHSS = National Institutes of Health Stroke Scale; mRS = modified Rankin scale; DWI = diffusion-weighted imaging.
Results
Of 101 subjects enrolled in the EPITHET study, 17 subjects were excluded due to lack of DWI with sufficient quality, and 13 lacked follow-up MRI. The clinical characteristics of the 71 patients included in the study are presented in Table 1 . Of the 71 included patients, 29 patients (40.8%) had a good outcome (mRS 0-2), while 42 patients (59.2%) had a poor outcome (mRS 3-6) at 90 days. Median values for the different imaging marker of mass effect in these two subgroups of patients with good and poor outcome at 90 days can be seen in Table 2 . Patients with poor outcome showed significantly greater midline shift, larger lesional swelling volumes, a larger change in ipsilateral hemisphere volume, and a larger ratio of hemisphere volumes compared to patients with good outcome. All of the examined markers of mass effect showed a high correlation with midline shift, as can be seen in Table 3 . Table 3 also shows the results of the ROC analysis for predicting poor outcome or mortality. Lesional swelling volume best discriminated patients with good versus poor outcome, with an area under the curve (AUC) of .791. The ratio of hemisphere volumes had a similar AUC of .753. The difference between the AUC for swelling volumes and the AUC for ratio of hemisphere volumes was not significant (P = .51). The other measures, including midline shift, performed less well in comparison (see Table 3 and Fig 2) . The AUC for midline shift was significantly lower than the AUC for lesional swelling volume (.682 vs. .791, P = .047). However, the AUC for baseline DWI volume was not significantly different from the AUC for swelling volume (.716 vs. .791, P = .17).
Of the 71 included patients, 12 patients (16.9%) did not survive the first 90 days after stroke.
For the discrimination of mortality, ROC curve analysis showed that lesional swelling volume, midline shift, and ratio of hemisphere volumes were equivalent (.661, .662, and .645, respectively, see Table 3 ).
Discussion
In this comparative analysis study, we demonstrated that several markers of mass effect, including midline shift, lesional swelling volume, CSF displacement, and hemispheric swelling, were intercorrelated, as expected. However, in the setting of Values are median (interquartile range); n = sample size; mRS = modified Rankin scale; FU = follow-up. P-values are calculated with the Mann-Whitney U test. * P < .01. Spearman's P is shown for correlation with midline shift. AUC = area under the curve; ROC = receiver-operating characteristics; mRS = modified Rankin scale; BL = baseline; FU = follow-up. ** P = <.0001, * P < .01.
Fig 2.
Receiver-operating characteristics (ROC) curves for the discrimination between good and poor outcome. ROC curve analysis showed that swelling volume (A) best discriminated patients with a modified Rankin scale score of 3-6 at 90 days with an area under the curve (AUC) of .79. The AUC for midline shift (B) and the ratio of hemisphere volumes (C) were lower. The difference between the AUC for swelling volume and the AUC for midline shift was significant (P = .047).
moderately sized stroke, we demonstrated that the traditional gold standard midline shift may not perform as well as lesional swelling volume, hemisphere ratio, or baseline DWI stroke lesion volume in predicting outcome. Midline shift discriminates patients with risk of early death in very large stroke lesions. 8 Our study demonstrates a less robust performance in predicting poor outcome, likely due to the smaller size in baseline stroke volumes. To shift the midline, swelling must be substantial, this makes midline shift less sensitive to smaller changes in swelling. Ventricle volume is also less sensitive, which may be related to the relatively low image quality on DWI and apparent diffusion coefficient (ADC) scans. Although validated in malignant edema, 5 CSF displacement may not be as sensitive for smaller lesions due to locationspecific effects. In contrast, lesional swelling volume and hemisphere ratio, as well as baseline DWI stroke lesion volume, were each strongly associated with outcome. It has been previously shown that in stroke patients with smaller stroke volumes, the amount of swelling predicts outcome. 9 Therefore, the precise measurement of swelling is an essential part in understanding and predicting clinical outcome progression after stroke, regardless of the stroke severity.
Several secondary neurological injury processes are associated with subsequent brain injury after the initial stroke. 22 Prediction of the course of the disease and potentially decisions about management and therapeutic options are dependent upon accurate assessment of the types of secondary neurological injury, including edema. A multitude of parameters, including the prestroke disability, NIHSS, comorbidities, age, family support, and quality of rehabilitation, greatly impacts the outcome of stroke patients at 90 days. This might be even more so in patients with mild to moderate stroke sizes. Our results suggest that the precise measurement of swelling volumes might be a useful parameter to consider in this process. Using measure like lesional swelling volumes or ratio or hemispheric volumes would improve the prediction of worse outcome in comparison to using midline shift or other markers.
Our study has several limitations. All the compared methods rely on spatial resolution of the images and movement artifacts and poor-quality images might affect them differently. Although we showed that lesional swelling volume is a better predictor of poor outcome than some other methods in our cohort, measuring it requires serial MRI and postacquisition analysis using specialized software. DWI baseline volume, midline shift, and ratio of hemisphere volumes have the advantage that the measurements can be made on a single scan, and are compatible with either CT or MR imaging acquisition. These measures might be an alternative to midline shift for more mildly affected stroke patients. Although some of the methods evaluated may not be practical for routine clinical care, they may nevertheless be of value as intermediate endpoints in studies that seek to understand the role of edema or in interventional studies that are designed to reduce edema formation. Another limitation is that the current techniques measure mass effect, a downstream consequence of edema accumulation, but they do not measure water content directly. While mass effect may have particular clinical relevance, the noninvasive measurement of water content, such as quantitative MRI 23 or CT hypoattenuation, 24 may provide additional information about brain edema and may further refine the predictive ability for outcome in patients. Further development of each of these approaches will facilitate the study of brain edema and its link to neurological outcome.
